跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-PACLITAXEL paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial - TGA Drug Approval Details
Approvals
/
TGA
/
APO-PACLITAXEL paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
Approved
STANDARD
APO-PACLITAXEL paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
KSJ Pharmatech
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
801df590f8cb3585
Company
KSJ Pharmatech
Type
Standard
Approval Details
Approval Id
801df590f8cb3585
Product Name
APO-PACLITAXEL paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
Artg Id
300355
Artg Name
APO-PACLITAXEL paclitaxel (nanoparticle albumin-bound) 100 mg powder for injection (suspension) vial
Sponsor
KSJ Pharmatech
Company Detail Path
/organization/ksj-pharmatech-limited
Artg Date
2020-02-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
801df590f8cb3585
Type
Standard
Back to TGA Approvals